Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that ...

Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

HOUSTON, JULY 1, 2026 ― A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...

Signal transduction and gene regulation are at the heart of cell and developmental biology, driving cell fate decisions and tissue homeostasis. In cancer, ...

Aging, at its most fundamental level, is a molecular process. Chemical marks on the genome shift and lose fidelity over time, ...

In oncology, the manipulation of metabolic processes within tumors has surfaced as a pivotal strategy for influencing cancer progression and therapy resistance. Tumor cells often undergo metabolic ...

Andy Lupini, distinguished R&D staff member of ORNL’s Electron Microscopy and Microanalysis Group, and Kevin Roccapriore — on entrepreneurial leave from ORNL’s Data NanoAnalytics Group to launch the ...

Abstract: Accurate and timely air quality prediction is crucial for cities and individuals to effectively take necessary precautions against potential air pollution. Existing studies typically rely on ...

A novel combination of mRNA technology and immune modulation may offer a new strategy for treating allergic diseases, according to new research demonstrating enhanced immune tolerance and reduced ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.